AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoformin VG 1mg/500mg/0.2mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Precia Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Endoformin VG 1mg/500mg/0.2mg Tablet ER

Diabex Trio 1mg/500mg/0.2mg Extended-Release Tablets are antidiabetic medications combining multiple agents to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose. Diabex Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counter them with fast-acting glucose sources (e.g., sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling (edema), blurry vision, fractures, and upper respiratory infections. Weight gain may occur. Do not use Diabex Trio if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended by your physician.

Uses of Endoformin VG 1mg/500mg/0.2mg Tablet ER

Managing type 2 diabetes

Major Benefits of Endoformin VG 1mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.

Common Side effects of Endoformin VG 1mg/500mg/0.2mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoformin VG 1mg/500mg/0.2mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.

How Endoformin VG 1mg/500mg/0.2mg Tablet ER works:

Extended-release Endoformin VG tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Endoformin VG tablet (1mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients experiencing severe kidney disease.

LiverLiverCAUTION

Patients with liver disease should use Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver impairment, initiation with a low dose of Endoformin VG 1mg/500mg/0.2mg Extended-Release tablets is typical; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Endoformin VG 1mg/500mg/0.2mg Tablet ER :

Should you forget a dose of Endoformin VG 1mg/500mg/0.2mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoformin VG 1mg/500mg/0.2mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Endoformin VG 1mg/500mg/0.2mg Tablet ER

Endoformin VG ER tablets (1mg/500mg/0.2mg) combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Endoformin VG 1mg/500mg/0.2mg ER tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Endoformin VG 1mg/500mg/0.2mg Tablet ER is contraindicated in patients with allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and metabolic acidosis (including diabetic ketoacidosis).
Combining Endoformin VG 1mg/500mg/0.2mg ER tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Endoformin VG 1mg/500mg/0.2mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Endoformin VG 1mg/500mg/0...
105
MRP 128
17% off